Loading clinical trials...
Loading clinical trials...
Validation and Reliability of the Turkish Version of the Parent-Reported Drug Hypersensitivity Quality of Life Questionnaire (P-DrHy-Q)
Conditions
Interventions
Turkish Version of the P-DrHy-Q
Locations
1
Turkey (Türkiye)
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Istanbul, Turkey (Türkiye)
Start Date
August 1, 2025
Primary Completion Date
October 30, 2025
Completion Date
October 30, 2025
Last Updated
December 8, 2025
NCT06821230
NCT06406114
NCT07168577
NCT07089797
NCT07343466
NCT06786130
Lead Sponsor
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions